The anti-inflammatory property elicited by ghrelin, together with its metabolic modulation, anti-apoptosis, anti-oxidant, and vasculoprotection mechanisms [15], implicate ghrelin as a versatile and effective drug not only in CPB but also in other inflammatory diseases, including stroke, sepsis, and shock [9], [10]. The gene discussed is GHRL; the disease is stroke disorder.